Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
22,055,151
-
Shares change
-
+5,102,651
-
Total reported value, excl. options
-
$223,420,734
-
Value change
-
+$51,494,354
-
Put/Call ratio
-
5.8%
-
Number of buys
-
48
-
Number of sells
-
-25
-
Price
-
$10.13
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2023
81 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,055,151 shares
of 44,542,200 outstanding shares and own 50% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4,110,709 shares), ORBIMED ADVISORS LLC (2,835,542 shares), First Light Asset Management, LLC (1,725,500 shares), AIGH Capital Management LLC (1,657,945 shares), Opaleye Management Inc. (1,580,000 shares), BlackRock Inc. (1,011,523 shares), Pentwater Capital Management LP (878,799 shares), VANGUARD GROUP INC (868,519 shares), NEXT CENTURY GROWTH INVESTORS LLC (774,912 shares), and Velan Capital Investment Management LP (746,087 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.